Home
About Us
Our Team
Our Facilities
Our Partners
Services
Behavorial Analyses
PK/PD correlation
Biochemical & Immunochemistry analyses
Sigma 1 receptor agonist/antagonist properties in vitro
Models
Neurodegenerative Diseases
Brain Aging
Brain Development
Neuropsychiatric Diseases
Amnesia
Publications
News
Events
Contact
Newsletter
Amylgen’s Articles & Posters
2013/03/14
Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer’s disease.
Authors :Lahmy V, Meunier J, Malmström S, Naert G, Givalois L, Kim SH, Villard V, Vamvakides A, Maurice T. Abstract: The main objective of the […]
2012/12/03
Increased amyloid-β peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice.
Authors: Desrumaux C, Pisoni A, Meunier J, Deckert V, Athias A, Perrier V, Villard V, Lagrost L, Verdier JM, Maurice T. Abstract :Oxidative stress […]
2012/11/02
The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer’s disease.
Authors : Meunier J1, Villard V, Givalois L, Maurice T Abstract : Alzheimer’s disease pathomimetic toxicity could be induced in mice within one week after […]
Prev page
1
2
3
We use cookies to ensure you get the best experience on our website
Find out more.
Ok